date,title,source
Oct-17-18,uniQure Presents New Data Demonstrating Its Large-Scale Manufacturing Capabilities at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting,GlobeNewswire
Oct-18-18,"uniQure Announces Development of a Highly Potent, Next-Generation Promoter for Liver-Directed Gene Therapies",GlobeNewswire
Oct-23-18,"Report: Exploring Fundamental Drivers Behind The Home Depot, uniQure N.V, Catalent, Apple, BioTime, and PDL BioPharma  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-31-18,uniQure to Participate in Multiple Upcoming Industry Conferences,GlobeNewswire
Nov-05-18,"uniQure to Host Research & Development Day on Monday, November 19 in New York City",GlobeNewswire
Nov-06-18,"UniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-06-18,UniQure: 3Q Earnings Snapshot,Associated Press
Nov-06-18,uniQure Announces Third Quarter 2018 Financial Results and Highlights Company Progress,GlobeNewswire
Nov-13-18,Options Traders Expect Huge Moves in uniQure (QURE) Stock,Zacks
Nov-15-18,Why uniQure N.V. Stock Is Skyrocketing Today,Motley Fool
Nov-15-18,uniQure Announces Initial Topline Data from Dose-Confirmation Study of AMT-061 in Patients with Hemophilia B,GlobeNewswire
Nov-16-18,Uniqure CEO discusses company's positive data in hemophil...,CNBC Videos
Nov-16-18,uniQure Up on Positive Data From Mid-Stage Hemophilia Study,Zacks
Nov-19-18,uniQure Highlights Pipeline Expansion and Advancements in Technology at Research & Development Day,GlobeNewswire
Nov-23-18,Novartis Gets Approval for Gene Therapy Luxturna in Europe,Zacks
Nov-29-18,"Bayer To Cut 12,000 Jobs Amid Strategic Overhaul To Focus On Pharma",Investor's Business Daily
Nov-30-18,"Analysis: Positioning to Benefit within Vivint Solar, uniQure N.V, Internap, Intuit, WideOpenWest, and Deere  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Dec-03-18,uniQure Announces Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 and Confirms Dose for AMT-061 Pivotal Study in Hemophilia B,GlobeNewswire
Dec-04-18,FDA Accepts BLA & Gives Priority Review to Novartis' AVXS-101,Zacks
Dec-12-18,Do Institutions Own uniQure N.V. (NASDAQ:QURE) Shares?,Simply Wall St.
Dec-18-18,Uniqure NV (QURE): Hedge Fund Sentiment Unchanged,Insider Monkey
Jan-22-19,uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntingtons Disease,GlobeNewswire
Jan-30-19,uniQure to Participate in Multiple Upcoming Industry Conferences,GlobeNewswire
Feb-04-19,uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of AMT-061 in Patients with Hemophilia B,GlobeNewswire
Feb-08-19,UniQure gene therapy shows rise in blood-clotting protein in trial,Reuters
Feb-08-19,uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B,GlobeNewswire
Feb-13-19,How Does Investing In uniQure N.V. (NASDAQ:QURE) Impact The Volatility Of Your Portfolio?,Simply Wall St.
Feb-15-19,uniQure Announces Publications on AAV Gene Therapy Approach to Treating Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) in the Journal Molecular Therapy Nucleic Acids,GlobeNewswire
Feb-22-19,"Investor Expectations to Drive Momentum within Graphic Packaging Holding, Vulcan Materials, Omeros, Koppers, uniQure N.V, and WAVE Life Sciences  Discovering Underlying Factors of Influence",GlobeNewswire
Feb-25-19,Sell-Side Picks Top Gene Therapy Takeout Candidates Following Spark Therapeutics Deal,Benzinga
Feb-26-19,Biotech ETFs Jump on Roche-Spark Deal,Zacks
Feb-26-19,Deal on the Way Now that Deadline is Delayed?,Zacks
Feb-26-19,5 Gene Therapy Stocks to Enrich Your Portfolio,Zacks
Feb-26-19,2 More Gene Therapy Stocks on Big Pharma's Buyout Radar,Motley Fool
Feb-27-19,"The Zacks Analyst Blog Highlights: Spark Therapeutics, Solid Biosciences, REGENXBIO, Editas Medicine and uniQure",Zacks
Feb-27-19,uniQure Presents New Preclinical Data on AMT-130 at the CHDIs 14th Annual Huntingtons Disease Therapeutics Conference,GlobeNewswire
Feb-28-19,uniQure Announces 2018 Financial Results and Highlights Recent Company Progress,GlobeNewswire
Mar-01-19,Why Big Pharma Is Diving Into Gene Therapy,Barrons.com
Mar-01-19,uniQure to Participate in Multiple Upcoming Industry Conferences,GlobeNewswire
Mar-29-19,uniQure to Participate in Multiple Upcoming Industry Conferences,GlobeNewswire
Apr-04-19,uniQure N.V. (NASDAQ:QURE): Financial Strength Analysis,Simply Wall St.
Apr-08-19,4 Gene Therapy Players Likely to Become Buyout Targets in 2019,Zacks
Apr-08-19,uniQure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntingtons Disease,GlobeNewswire
Apr-12-19,Want an insiders way to play IPOs? This fund has had outsize success with its strategy,MarketWatch
Apr-15-19,uniQure Announces Presentations at the Upcoming Annual Meeting of The American Society of Gene and Cell Therapy (ASGCT),GlobeNewswire
Apr-15-19,Want an insiders way to play IPOs? This fund has had outsize success with its strategy,MarketWatch
Apr-29-19,UniQure: 1Q Earnings Snapshot,Associated Press
Apr-29-19,uniQure Announces First Quarter 2019 Results and Highlights Recent Company Progress,GlobeNewswire
May-01-19,uniQure to Participate in Multiple Upcoming Industry Conferences,GlobeNewswire
May-02-19,Did Hedge Funds Drop The Ball On Uniqure NV (QURE) ?,Insider Monkey
May-02-19,uniQure Announces New Preclinical Data in Hemophilia A and Fabry Disease in Oral Presentations at the 22nd ASGCT Annual Meeting,GlobeNewswire
May-07-19,uniQure Announces Featured Presentations of New Data on Spinocerebellar Ataxia Type 3 at the 2019 American Academy of Neurology Annual Meeting,GlobeNewswire
May-10-19,This Gene Therapy Stock Is Nearing A Breakout On Its Hemophilia B Study,Investor's Business Daily
May-10-19,uniQure N.V. (NASDAQ:QURE) Insiders Have Been Selling,Simply Wall St.
May-10-19,uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B,GlobeNewswire
May-22-19,uniQure Strengthens Intellectual Property Portfolio with Granted Patent Claims Covering AMT-130 for Huntingtons Disease,GlobeNewswire
May-30-19,3 Top Gene Therapy Stocks That Could Soar,InvestorPlace
May-31-19,uniQure to Participate in Multiple Upcoming Industry Conferences,GlobeNewswire
Jun-04-19,uniQure (QURE) Jumps: Stock Rises 8.9%,Zacks
Jun-05-19,AMD and 3 more momentum stocks to watch,MarketWatch
Jun-05-19,An Intrinsic Calculation For uniQure N.V. (NASDAQ:QURE) Suggests It's 29% Undervalued,Simply Wall St.
